SCHEMBL25820611

SCHEMBL25820611

Cc1cc(NC(=O)c2cccc(Nc3ccnc4ccc(C#N)cc34)c2)cc(Nc2ccccc2)c1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DNMT1 P26358 8/20 0.58
DNMT3A Q9Y6K1 7/20 0.58
DNMT3L Q9UJW3 5/20 0.51
EHMT1 Q9H9B1 3/20 0.51
MAPKAPK2 P49137 2/20 0.48
GAK O14976 1/20 0.48
RIPK2 O43353 1/20 0.48
COQ8A Q8NI60 1/20 0.48
NLK Q9UBE8 1/20 0.48
BRAF P15056 4/20 0.47
CCNC P24863 1/20 0.43
CDK8 P49336 1/20 0.43
MYC P01106 1/20 0.42
MAP2K3 P46734 1/20 0.42
EHMT2 Q96KQ7 1/20 0.42
DNMT3B Q9UBC3 1/20 0.42
USP2 O75604 1/20 0.41
MAPT P10636 1/20 0.41
KMT2A Q03164 1/20 0.41
EGFR P00533 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25487274 0.95 DNMT1 (0.54) DNMT1DNMT3ADNMT3LEHMT1MAPKAPK2
SCHEMBL25820603 0.95 DNMT1 (0.53) DNMT1DNMT3ADNMT3LEHMT1MAPKAPK2
SCHEMBL25820730 0.93 DNMT1 (0.64) DNMT1DNMT3ADNMT3LEHMT1MAPKAPK2
SCHEMBL24010972 0.93 DNMT1 (0.64) DNMT1DNMT3ADNMT3LEHMT1MAPKAPK2
SCHEMBL25820628 0.91 DNMT1 (0.58) DNMT1DNMT3ADNMT3LEHMT1MAPKAPK2
SCHEMBL24006169 0.91 DNMT1 (0.70) DNMT1DNMT3ADNMT3LEHMT1MAPKAPK2
SCHEMBL24011129 0.90 DNMT1 (0.49) DNMT1DNMT3ADNMT3LEHMT1MAPKAPK2
SCHEMBL25820597 0.89 DNMT1 (0.59) DNMT1DNMT3ADNMT3LEHMT1MAPKAPK2
SCHEMBL25820613 0.88 DNMT1 (0.61) DNMT1DNMT3ADNMT3LEHMT1MAPKAPK2
SCHEMBL25820609 0.88 DNMT1 (0.58) DNMT1DNMT3ADNMT3LEHMT1MAPKAPK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230219927-A1 AKT3 MODULATORS Georgiamune Inc. 2023-07-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230219927-A1 AKT3 MODULATORS AKT3, AKT2, PIK3CA DNMT1 4335/4885DNMT3A 4603/4885DNMT3L 4609/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.